BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8740317)

  • 21. Genotype-phenotype correlation of xeroderma pigmentosum in a Chinese Han population.
    Sun Z; Zhang J; Guo Y; Ni C; Liang J; Cheng R; Li M; Yao Z
    Br J Dermatol; 2015 Apr; 172(4):1096-102. PubMed ID: 25256075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carcinogen-induced inflammation and immunosuppression are enhanced in xeroderma pigmentosum group A model mice associated with hyperproduction of prostaglandin E2.
    Miyauchi-Hashimoto H; Kuwamoto K; Urade Y; Tanaka K; Horio T
    J Immunol; 2001 May; 166(9):5782-91. PubMed ID: 11313422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurological manifestations of xeroderma pigmentosum due to
    Salomão RPA; Pedroso JL; Barsottini OGP
    Pract Neurol; 2018 Dec; 18(6):489-491. PubMed ID: 30077970
    [No Abstract]   [Full Text] [Related]  

  • 24. Mutational analysis of a function of xeroderma pigmentosum group A (XPA) protein in strand-specific DNA repair.
    Kobayashi T; Takeuchi S; Saijo M; Nakatsu Y; Morioka H; Otsuka E; Wakasugi M; Nikaido O; Tanaka K
    Nucleic Acids Res; 1998 Oct; 26(20):4662-8. PubMed ID: 9753735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultraviolet-B induced hyperplasia and squamous cell carcinomas in the cornea of XPA-deficient mice.
    De Vries A; Gorgels TG; Berg RJ; Jansen GH; Van Steeg H
    Exp Eye Res; 1998 Jul; 67(1):53-9. PubMed ID: 9702178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling xeroderma pigmentosum associated neurological pathologies with patients-derived iPSCs.
    Fu L; Xu X; Ren R; Wu J; Zhang W; Yang J; Ren X; Wang S; Zhao Y; Sun L; Yu Y; Wang Z; Yang Z; Yuan Y; Qiao J; Izpisua Belmonte JC; Qu J; Liu GH
    Protein Cell; 2016 Mar; 7(3):210-21. PubMed ID: 26874523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The present status of xeroderma pigmentosum in Japan and a tentative severity classification scale.
    Nakano E; Masaki T; Kanda F; Ono R; Takeuchi S; Moriwaki S; Nishigori C
    Exp Dermatol; 2016 Aug; 25 Suppl 3():28-33. PubMed ID: 27539899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel XPA gene mutation and its functional analysis in a Japanese patient with xeroderma pigmentosum group A.
    Tanioka M; Budiyant A; Ueda T; Nagano T; Ichihashi M; Miyachi Y; Nishigori C
    J Invest Dermatol; 2005 Aug; 125(2):244-6. PubMed ID: 16098033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Xeroderma Pigmentosa Group A (XPA), Nucleotide Excision Repair and Regulation by ATR in Response to Ultraviolet Irradiation.
    Musich PR; Li Z; Zou Y
    Adv Exp Med Biol; 2017; 996():41-54. PubMed ID: 29124689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin.
    Rosenberg E; Taher MM; Kuemmerle NB; Farnsworth J; Valerie K
    Cancer Res; 2001 Jan; 61(2):764-70. PubMed ID: 11212280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel mutation in the XPA gene results in two truncated protein variants and leads to a severe XP/neurological symptoms phenotype.
    Lehmann J; Schubert S; Schäfer A; Laspe P; Haenssle HA; Ohlenbusch A; Gratchev A; Emmert S
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2479-82. PubMed ID: 25393472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of Xeroderma Pigmentosum-A Patient-Derived Induced Pluripotent Stem Cell Line for Use As Future Disease Model.
    Ohnishi H; Kawasaki T; Deguchi T; Yuba S
    Cell Reprogram; 2015 Aug; 17(4):268-74. PubMed ID: 26090552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In silico characterization of a novel pathogenic deletion mutation identified in XPA gene in a Pakistani family with severe xeroderma pigmentosum.
    Nasir M; Ahmad N; Sieber CM; Latif A; Malik SA; Hameed A
    J Biomed Sci; 2013 Sep; 20(1):70. PubMed ID: 24063568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of cells harboring a putative DNA repair gene reveals a lack of evidence for a second independent xeroderma pigmentosum group A correcting gene.
    Jones CJ; Lloyd RS; Wood RD
    Mutat Res; 1994 Aug; 324(4):159-64. PubMed ID: 7519740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe phenotypes in two Tunisian families with novel XPA mutations: evidence for a correlation between mutation location and disease severity.
    Messaoud O; Rekaya MB; Ouragini H; Benfadhel S; Azaiez H; Kefi R; Gouider-Khouja N; Mokhtar I; Amouri A; Boubaker MS; Zghal M; Abdelhak S
    Arch Dermatol Res; 2012 Mar; 304(2):171-6. PubMed ID: 22081045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High levels of oxidatively generated DNA damage 8,5'-cyclo-2'-deoxyadenosine accumulate in the brain tissues of xeroderma pigmentosum group A gene-knockout mice.
    Mori T; Nakane H; Iwamoto T; Krokidis MG; Chatgilialoglu C; Tanaka K; Kaidoh T; Hasegawa M; Sugiura S
    DNA Repair (Amst); 2019 Aug; 80():52-58. PubMed ID: 31279170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of DNA repair deficiency in the confirmed heterozygotes of xeroderma pigmentosum group A.
    Moriwaki S; Nishigori C; Teramoto T; Tanaka T; Kore-eda S; Takebe H; Imamura S
    J Invest Dermatol; 1993 Jul; 101(1):69-72. PubMed ID: 8101209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclosporin A inhibits nucleotide excision repair via downregulation of the xeroderma pigmentosum group A and G proteins, which is mediated by calcineurin inhibition.
    Kuschal C; Thoms KM; Boeckmann L; Laspe P; Apel A; Schön MP; Emmert S
    Exp Dermatol; 2011 Oct; 20(10):795-9. PubMed ID: 21707758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene.
    Nakane H; Takeuchi S; Yuba S; Saijo M; Nakatsu Y; Murai H; Nakatsuru Y; Ishikawa T; Hirota S; Kitamura Y
    Nature; 1995 Sep; 377(6545):165-8. PubMed ID: 7675085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An altered redox balance and increased genetic instability characterize primary fibroblasts derived from xeroderma pigmentosum group A patients.
    Parlanti E; Pietraforte D; Iorio E; Visentin S; De Nuccio C; Zijno A; D'Errico M; Simonelli V; Sanchez M; Fattibene P; Falchi M; Dogliotti E
    Mutat Res; 2015 Dec; 782():34-43. PubMed ID: 26546826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.